Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

83.2K
Overview
83.2K
Vaccinations01:51

Vaccinations

51.1K
Overview
51.1K
Development of Immunocompetence01:22

Development of Immunocompetence

769
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
769
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.9K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.9K
Immunological Memory01:23

Immunological Memory

14.9K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
14.9K
Cross-reactivity00:42

Cross-reactivity

32.8K
Overview
32.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retinoic acid and FGF signaling interact to control elongation and lineage specification in a mouse gastruloid model.

Development (Cambridge, England)·2026
Same author

Can malaria induce loss of vaccine immunity.

The Journal of infectious diseases·2026
Same author

Apurinic/apyrimidinic endonuclease 1 prevents oxidative DNA damage in intestinal epithelial cells induced by genotoxic Escherichia coli NC101.

Redox biology·2026
Same author

Intranasal monoclonal antibodies do not prevent respiratory infection in a randomized, controlled experimental infection trial.

npj drug discovery·2026
Same author

Inequalities in breast cancer early detection, timeliness of care and survival in Colombia.

Cancer epidemiology·2026
Same author

Response to vaccination and immune status after intrauterine exposure to immunomodulating drugs for maternal IBD.

NPJ vaccines·2026

Related Experiment Video

Updated: Jan 7, 2026

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.3K

Antibody concentration and function following SARS-CoV-2 vaccination decrease with age in adults and children with

Bianca M M Streng1, Lobke C M Hensen2, Eveline M Delemarre2

  • 1Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.

Vaccine
|December 25, 2025
PubMed
Summary

Individuals with Down syndrome (DS) show reduced antibody responses and neutralization after COVID-19 vaccination compared to healthy controls. Vaccine effectiveness in DS is age-dependent, necessitating tailored immunization strategies.

Keywords:
AntibodyDown syndromeImmune responseSARS-CoV-2 vaccination

More Related Videos

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

2.2K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.7K

Related Experiment Videos

Last Updated: Jan 7, 2026

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.3K
Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

2.2K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.7K

Area of Science:

  • Immunology
  • Vaccinology
  • Genetics

Background:

  • Individuals with Down syndrome (DS) exhibit immune system alterations, leading to increased susceptibility to infections like SARS-CoV-2.
  • Previous research indicated diminished antibody levels post-primary SARS-CoV-2 vaccination in adults with DS.
  • This study prospectively examines antibody responses and functionality following primary and booster COVID-19 vaccination in both children and adults with DS.

Purpose of the Study:

  • To evaluate and compare antibody concentrations and neutralizing titers after SARS-CoV-2 primary and booster vaccination in individuals with Down syndrome (DS) versus healthy controls (HC).
  • To investigate the impact of age on vaccine response in individuals with DS.
  • To determine if vaccine response defects in DS are consistent across different vaccine types (mRNA and vector-based).

Main Methods:

  • Prospective study measuring anti-S and anti-RBD antibody concentrations and virus neutralizing titers (ID50) post-vaccination.
  • Participants included adults (N=215 DS, N=93 HC) and children with DS, receiving mRNA or vector-based primary vaccines and mRNA boosters.
  • Antibody levels and neutralization capacity were compared between DS and HC groups, and analyzed for age-related trends within the DS cohort.

Main Results:

  • All participants showed increased antibody concentrations post-vaccination, but individuals with DS consistently had lower anti-S and anti-RBD antibody levels than HC, irrespective of primary vaccine type.
  • In the DS group, anti-S antibody concentrations decreased with age; teenagers (12-17 years) had the highest levels, while younger children (<12 years) had significantly lower levels.
  • Serum neutralization was significantly lower in adults with DS compared to HC after both mRNA and vector-based primary vaccination.

Conclusions:

  • This is the first vaccine immunology study in Down syndrome (DS) encompassing both children and adults.
  • Individuals with DS exhibit reduced antibody concentrations and serum neutralization following primary and booster SARS-CoV-2 vaccination compared to healthy controls.
  • The observed vaccine response defects in DS are age-dependent, underscoring the need for age-specific immunization strategies in this population.